|
|
||||||||
a Department of Pediatrics, Shinshu University School of Medicine, Matsumoto, Japan;
b Blood Transfusion Service, Shinshu University Hospital, Matsumoto, Japan;
c Pharmaceutical Research Laboratory, Kirin Brewery Co. Ltd., Takasaki, Japan
Key Words. Thrombopoietin • Apoptosis • CD34/CD41 cells • c-Mpl • Erythroid differentiation • Cord blood cells
Dr. Kenichi Koike, Department of Pediatrics, Shinshu University School of Medicine, 3-1-1, Asahi, Matsumoto, 390, Japan.
Although the effect of thrombopoietin (TPO) on megakaryocyte production is well established, its role in the commitment of multipotential hematopoietic progenitors to the megakaryocytic lineage remains to be determined. In the present study, we attempted to clarify the determination process of megakaryocytic lineage as a terminal differentiation pathway under stimulation with TPO. Day 7 cultured cells grown by TPO derived from cord blood CD34+ cells were divided into four subpopulations on the basis of CD34 and CD41 expression. The CD34/CD41 cells showed the labeling pattern of anti-CD42b and anti-CD9 antibodies closer to that of the CD34+/CD41 cells than the CD34+/CD41+ cells. Replating experiments revealed that approximately 40% of the CD34/CD41 cells proliferated in response to a combination of growth factors, and more than 80% of them were pure erythroid precursors. However, this subpopulation failed to grow/survive and fell into apoptosis in the presence of TPO alone. In contrast, the CD34+/CD41+ cells, which predominantly contained megakaryocytic precursors, exerted a low but significant proliferative potential in the presence of TPO. The insufficient response to TPO of the CD34/CD41 cells may result from the apparently low expression of c-Mpl, as determined by flow cytometric analysis and reverse transcription-polymerase chain reaction analysis. Therefore, these results suggest that the apoptosis of hematopoietic precursors other than megakaryocytic precursors is related to the determination of the terminal differentiation under the influence of TPO.
This article has been cited by other articles:
![]() |
K. Takeuchi, K. Koike, T. Kamijo, S. Ishida, Y. Nakazawa, Y. Kurokawa, K. Sakashita, T. Kinoshita, S. Matsuzawa, M. Shiohara, et al. STI571 inhibits growth and adhesion of human mast cells in culture J. Leukoc. Biol., December 1, 2003; 74(6): 1026 - 1034. [Abstract] [Full Text] |
||||
![]() |
A. N. Goldfarb, D. Wong, and F. K. Racke Induction of Megakaryocytic Differentiation in Primary Human Erythroblasts : A Physiological Basis for Leukemic Lineage Plasticity Am. J. Pathol., April 1, 2001; 158(4): 1191 - 1198. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| STEM CELLS | THE ONCOLOGIST | CME | ALPHAMED PRESS JOURNALS |
